PACT Pharma

PACT Pharma

PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.

Edit ID  8719207 

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 17 Nov 2018 12:24 am
Edits made to:
Article (+13/-13 characters)


PACT Pharma raised $95 million in Series B financing. Alphabet Inc.Alphabet Inc.'s venture arm GV led the round, with participation from Invus Group, Canaan Partners, Casdin Capital, Wu Capital and other undisclosed investors.